Aristotelis Bamias, MD, Ph.D., is a Professor at the Medical School, University of Athens, Greece, and Head of the 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital. He studied Μedicine in the Medical School of the University of Athens and trained in Ιnternal Μedicine and Μedical Οncology in the UK, where he obtained his Ph.D. at the University of London and served as a Lecturer in Medical Oncology. He is a founding member and Chair of the Hellenic Genito-Urinary Cancer Group (HGUCG). He is a member of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) and the Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators. Professor Bamias has been a member of the European Society of Μedical Οncology (ESMO) Faculty for Genitourinary Cancer since 2012, and he has been chairing this group since 2016. His main research focus in oncology is urogenital and gynecological tumors. A member of several international advisory boards and steering committees of international trials, he has authored or co-authored more than 280 original papers and reviews in peer-reviewed journals, including N Engl J Med, Lancet, Lancet Oncology, and J Clin Oncol, with more than 13000 citations by other authors and a h-index of 56.
Research Keywords & Expertise
Chemotherapy
Ovarian Cancer
renal cancer
urothelial cancer
immune check point inh...
Fingerprints
Chemotherapy
Ovarian Cancer
urothelial cancer
renal cancer
Short Biography
Aristotelis Bamias, MD, Ph.D., is a Professor at the Medical School, University of Athens, Greece, and Head of the 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital. He studied Μedicine in the Medical School of the University of Athens and trained in Ιnternal Μedicine and Μedical Οncology in the UK, where he obtained his Ph.D. at the University of London and served as a Lecturer in Medical Oncology. He is a founding member and Chair of the Hellenic Genito-Urinary Cancer Group (HGUCG). He is a member of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) and the Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators. Professor Bamias has been a member of the European Society of Μedical Οncology (ESMO) Faculty for Genitourinary Cancer since 2012, and he has been chairing this group since 2016. His main research focus in oncology is urogenital and gynecological tumors. A member of several international advisory boards and steering committees of international trials, he has authored or co-authored more than 280 original papers and reviews in peer-reviewed journals, including N Engl J Med, Lancet, Lancet Oncology, and J Clin Oncol, with more than 13000 citations by other authors and a h-index of 56.
